Lead Specialty Practice Pharmacist, Infectious Diseases
The Ohio State University Wexner Medical Center
368 Doan Hall
410 W. 10th Avenue
Columbus, OH 43210
614-293-6580
Jessica.Smith4@osumc.edu
Professional Interests
My practice interests include general infectious diseases, antimicrobial and laboratory stewardship, and vaccines.
Education and Training
PGY2 Infectious Diseases Pharmacy Residency: Wake Forest Baptist Health, Winston-Salem, NC, 2017-2018
PGY1 Pharmacy Residency: Wake Forest Baptist Health, Winston-Salem, NC, 2016-2017
PharmD: University of Tennessee Health Sciences Center, Memphis, TN, 2012-2016
MBA: University of Memphis Fogelman College of Business & Economics, Memphis, TN, 2013-2016
BS: Chemistry, Furman University, Greenville, SC, 2008-2012
Professional Memberships
American College of Clinical Pharmacy (ACCP)
Society of Infectious Diseases Pharmacists (SIDP)
Honors and Awards
OSUWMC Residency Preceptor of the Year Award, 2021
Cluck DB, Smith J. Interactive Case: Long-Acting Lipoglycopeptides for SSTIs. Dodds Ashley ES, Gross AE, eds. In: IDSAP 2023 Book 1: SSTI, Bone and Joint Infections, and Outpatient Antimicrobial Stewardship. ACCP; 2023. ISBN-13: 978-1-952291-72-2.
Cid A, Smetana M, Coe K, Hebert C, Smith JM. Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk. Pharmacotherapy. 2022;42(12):880-889.
Aycock A, Smith J, Coe K, Wang S, Reed E. Association between vancomycin AUC and clinical failure in patients with streptococcal bacteremia. Hospital Pharmacy. 2022;58(3):289-294. doi: 10.1177/00185787221139424.
Cash MC, Hile G, Johnson J, Stone T, Smith J, Ohl C, Luther V, Beardsley J. Sustained impact of an antibiotic stewardship initiative targeting asymptomatic bacteriuria and pyuria in the emergency department. Antimicrobial Stewardship & Healthcare Epidemiology. 2022;2(1):e148. doi: https://doi.org/10/1017/ash.2022.289
Bolker A, Coe K, Smith J, Stevenson K, Wang SH, Reed E. Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients. Diagn Microbiol Infect Dis. 2022 Jan;102(1):115558. doi: 10.1016/j.diagmicrobio.2021.115558.
Agnello S, Wardlow LC, Reed E, Smith JM, Coe K, Day SR. Clinical outcomes of daptomycin versus anti-staphylococcal beta-lactams in definitive treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections. Int J Antimicrob Agents. 2021; doi: 10.1016/j.ijantimicag.2021.106.
Rinaldi A, Reed EE, Stevenson KB, Coe K, Smith JM. Effectiveness of fidaxomicin versus oral vancomycin in the treatment of recurrent Clostridioides difficile. J Clin Pharm Ther. 2021;00:1-6. doi: 10.1111/jcpt.13387.
Vlashyn OO, Lorenz AM, Sobhanie MM, Smith JM, Bond M, Wardlow L. Safety outcomes with high-dose daptomycin in patients with acute kidney injury and/or end-stage renal disease. J Clin Pharm Ther. 2020;00:1-6. doi: 10.1111/jcpt.13289